| 000 | 01258 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517113248.0 | ||
| 264 | 0 | _c20170529 | |
| 008 | 201705s 0 0 eng d | ||
| 022 | _a1744-7623 | ||
| 024 | 7 |
_a10.1080/14728214.2016.1220535 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMatos, Ignacio | |
| 245 | 0 | 0 |
_aEmerging tyrosine kinase inhibitors for the treatment of metastatic colorectal cancer. _h[electronic resource] |
| 260 |
_bExpert opinion on emerging drugs _cSep 2016 |
||
| 300 |
_a267-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aElez, Elena | |
| 700 | 1 | _aCapdevila, Jaume | |
| 700 | 1 | _aTabernero, Josep | |
| 773 | 0 |
_tExpert opinion on emerging drugs _gvol. 21 _gno. 3 _gp. 267-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/14728214.2016.1220535 _zAvailable from publisher's website |
| 999 |
_c26375464 _d26375464 |
||